Fingerprint Dive into the research topics of 'Risk-adjusted therapy for pediatric non-T cell ALL improves outcomes for standard risk patients: results of JACLS ALL-02'. Together they form a unique fingerprint.
- Sort by
- Weight
- Alphabetically
Risk-adjusted therapy for pediatric non-T cell ALL improves outcomes for standard risk patients: results of JACLS ALL-02
for the Japan Association of Childhood Leukemia Study Group (JACLS)
Research output: Contribution to journal › Article › peer-review
3
Citations
(Scopus)